Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03015454 · ClinicalTrials.gov registry record · NA
An Algorithm Driven Sepsis Prediction Biomarker
A NA study, sponsored by Dascena.
- Completed
- Registry status
- NA
- Development phase
- 142
- Enrollment target
NCT03015454: Completed NA study, sponsored by Dascena.
NCT03015454 is a NA study that has completed, run by Dascena. The registered enrollment target is 142 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03015454, a NA study, has completed, sponsored by Dascena.
- COMPLETED
- Registry status
- NA
- Development phase
- 142 participants
- Enrollment target
Study Summary
A sepsis early warning predictive algorithm, InSight, has been developed and validated on a large, diverse patient cohort. In this prospective study, the ability of InSight to predict severe sepsis patients is investigated. Specifically, InSight is compared with a well established severe sepsis detector in the UCSF electronic health record (EHR).
Interventions
- OTHER Severe Sepsis Prediction
- OTHER Severe Sepsis Detection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 142 participants |
| Start Date | 2016-12 |
| Phase | NA |
What the finished NCT03015454 record still lists
NCT03015454 is an interventional study that assigns participants to a tested intervention. The registered 142 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 2 interventions - of which Severe Sepsis Prediction is the first listed.
NCT03015454 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03015454 about?
NCT03015454 is a clinical study titled "An Algorithm Driven Sepsis Prediction Biomarker". A sepsis early warning predictive algorithm, InSight, has been developed and validated on a large, diverse patient cohort. In this prospective study, the ability of InSight to predict severe sepsis patients is investigated. Specifically, InSight is compared with a well established severe sepsis dete...
What is the current status of trial NCT03015454?
This trial is currently completed. It is a NA study. The enrollment target is 142 participants. The study started on 2016-12.
What interventions are being tested in trial NCT03015454?
The interventions under investigation include: Severe Sepsis Prediction (OTHER), Severe Sepsis Detection (OTHER).
Who is sponsoring clinical trial NCT03015454?
This trial is sponsored by Dascena, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03015454's enrollment target sits among peer trials
142 711th of 2000 higher than 1,289 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03933631 · 142 participants · Phase 3
Pilocarpine Use After Kahook Goniotomy
- NCT04938349 · 142 participants · NA
Dual Task Perturbation Training for OAwMCI
- NCT06117254 · 142 participants · NA
Hearing Aids for Veterans With Functional Hearing Difficulties
- NCT06463665 · 142 participants · Phase 2
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia